SunOpta Inc. Earnings Presentation Q3 2025 © SunOpta Inc. 2025 1 1 Better Beverages, Better Snacks, Better Solutions SunOpta Inc. Earnings Presentation Q3 2025 General Disclosures This presentation contains forward-looking statements that reflect the Company's current views about future events and financial performance. These forward-looking statements are subject to important risks and uncertainties, as well as other factors and assumptions that could cause actual results to differ materially from those an ...

Vir Biotechnology (NasdaqGS:VIR) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Speaker2Hello and welcome to Vir Biotechnology's third quarter 2025 financial results and corporate update call. As a reminder, this conference call is being recorded. At this time, all participants are in a listen-only mode. After the speaker's remarks, there will be a question-and-answer session. I will now turn the call over to Jason O'Byrne, Chief Financial Officer. Please go ahead.Speaker1Thank you and good afternoon. ...

SkyWater (NasdaqCM:SKYT) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Speaker2Hello, and thank you for standing by. My name is Lacey, and I will be your conference operator today. At this time, I would like to welcome everyone to the SkyWater Technology Third Quarter 2025 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, s ...

CONMED (NYSE:CNMD) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Speaker1Good day and thank you for standing by. Welcome to ConMed's third quarter fiscal 2025 earnings conference call. At this time, all participants are in a listen only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, ...

ADMA Biologics (NasdaqGM:ADMA) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Speaker0Good afternoon, and welcome to the ADMA Biologics third quarter 2025 financial results and business update conference call on Wednesday, November 5th, 2025. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request and will be available on the company's website approximately two hours foll ...

Financial Data and Key Metrics Changes - Revenue for Q3 2025 reached a record $23.1 million, up 21% year-over-year [6][12] - Adjusted gross profit was a record $19.4 million, resulting in an adjusted gross margin of 84%, up one percentage point [6][12] - Adjusted EBITDA for the quarter was a record $9 million, an increase of 35% year-over-year, with an adjusted EBITDA margin of 39%, up four percentage points [12] - Adjusted net income increased 75% to a record $5.8 million, resulting in adjusted earnings of $0.39 per diluted share [12][17] - Free cash flow for the quarter was a record $7.3 million, a 51% increase from $4.8 million a year ago [17] Business Line Data and Key Metrics Changes - IDI added over 300 customers, ending the quarter with over 9,800 customers [6][12] - Forewarn added over 25,000 users, with over 590 realtor associations contracted [6][12] - The investigative vertical showed strong performance, driven by demand from law enforcement and investigative customers [12][14] - The emerging markets vertical, including retail, legal, repossession, government, and healthcare, contributed to growth [12][14] - Collections experienced high teens revenue growth, indicating a steady recovery [14] Market Data and Key Metrics Changes - Government sector wins included contracts with state toll authorities and departments of revenue, indicating strong public sector performance [7][22] - Gross revenue retention remained strong at 96%, improving by two percentage points year-over-year [15] Company Strategy and Development Direction - The company continues to invest in platform capabilities, product advancements, and AI integration to enhance competitive advantages [6][8] - The strategic focus is on expanding go-to-market capabilities and enhancing proprietary data assets [8][9] - A $15 million increase to the share repurchase program was announced, reflecting confidence in the company's growth trajectory [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in closing out 2025 as another record year, supported by a strong sales pipeline and disciplined execution [11][18] - The company is excited about the opportunities in the public sector and background screening markets, anticipating significant growth in 2026 [22][25] Other Important Information - Cash and cash equivalents were $45.4 million at the end of Q3 2025, up from $36.5 million at year-end 2024 [17] - The company purchased 15,437 shares at an average price of $42.26 during the quarter [17] Q&A Session Summary Question: Details on traction with larger public and enterprise sector customers - Management highlighted investments in the public sector division and background screening solutions, noting recent wins with state toll authorities and large payroll processors [22][23] Question: Addressable market for large toll authorities and payroll processing - Management indicated that every state has some form of toll authority, presenting substantial market opportunities, and emphasized the enormous background screening industry [24][25] Question: Renewals and ARPU growth for Forewarn - Management confirmed strong renewals and retention rates for Forewarn, with plans to add features that could enhance pricing during renewals [30][32] Question: Customer pipeline for Q4 - Management expressed excitement about the strong customer pipeline but noted potential seasonal slowdowns in Q4 due to fewer business days [34] Question: Expectations for gross margin in Q4 - Management expects gross margins to remain consistent with Q3 levels, around 82%-84% [38] Question: Attractiveness of current share price for buyback - Management affirmed that the current share price is attractive and emphasized the importance of investing in the business for long-term growth [39]

Adaptive Biotechnologies (NasdaqGS:ADPT) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Speaker2Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies third-quarter earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is rai ...

Evolus (NasdaqGM:EOLS) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Speaker0Good afternoon, everyone, and thank you for standing by. Welcome to Evolus' Third Quarter Earnings Conference Call. As a reminder, today's conference is being recorded and webcast live. All participants are in a listen only mode. After the speakers' remarks, there will be a question and answer session.I would now like to turn the conference over to Narek Segarian, Vice President and Head of Global Investor Relations and Corpo ...

e.l.f. Beauty (NYSE:ELF) Q2 2026 Earnings Call November 05, 2025 04:30 PM ET Speaker3Thank you for joining us today to discuss e.l.f. Beauty's second quarter fiscal 2026 results. I'm KC Katten, Vice President of Corporate Development and Investor Relations. With me today are Tarang Amin, Chairman and Chief Executive Officer, and Mandy Fields, Senior Vice President and Chief Financial Officer. We encourage you to tune into our webcast presentation for the best viewing experience, which you can access on our ...

B&G Foods (NYSE:BGS) Q3 2025 Earnings Call November 05, 2025 04:30 PM ET Speaker2Good day and welcome to the B&G Foods Third Quarter 2025 Financial Results Conference Call. Today's call, which is being recorded, is scheduled to last about one hour, including remarks by B&G Foods management and the question and answer session. I would now like to turn the call over to AJ Schwab, Senior Associate, Corporate Strategy and Business Development for B&G Foods. Thank you and over to you.Speaker5Good afternoon and t ...